# Moschovakis Capital

> Logic over Emotion. Wealth over Time.

**Last Updated: 2026-08-17**

Moschovakis Capital is an independent financial research and automated trading firm founded by Angelos Moschovakis, based in Heraklion, Crete, Greece. The firm operates two verified business lines: (1) a fully automated FX execution system with 24+ months of independently audited performance, and (2) deep fundamental equity research covering 107 global companies across 120 published analyses, using a proprietary Wealth Preservation Framework.

All equity research is published with real capital backing. Angelos Moschovakis is a verified eToro Popular Investor — every stock thesis is executed with personal capital in a publicly visible portfolio. The FX trading system is independently audited by both Myfxbook and MQL5, with every trade, drawdown, and recovery on public record since 2024.

## About the Analyst

Angelos Moschovakis is the founder, sole analyst, and portfolio manager at Moschovakis Capital. He developed the proprietary Wealth Preservation (WP) Score framework — an 8-dimension scoring system that evaluates equities on balance sheet strength, profitability durability, valuation margin of safety, dividend sustainability, management quality, competitive moat, downside scenario modeling, and catalyst identification.

- eToro Popular Investor with publicly tracked equity portfolio
- 24+ months of verified algorithmic FX trading via Myfxbook and MQL5
- 1,083+ documented trades with full drawdown/recovery data
- Publisher on Substack with institutional-grade equity research

## Proprietary Methodology: The Wealth Preservation Score

The WP Score is a quantitative framework scored out of 100 that evaluates equities across eight dimensions:

1. **Balance Sheet Fortress** — Net debt/EBITDA, current ratio, interest coverage, equity position
2. **Profitability Durability** — ROIC vs WACC, gross/operating margins, free cash flow consistency
3. **Valuation Margin of Safety** — DCF fair value, probability-weighted scenario modeling (bull/base/bear)
4. **Dividend Sustainability** — Payout ratio, growth streak, yield vs sector median
5. **Management Quality** — Capital allocation track record, insider ownership, governance
6. **Competitive Moat** — Switching costs, network effects, intangible assets, cost advantages
7. **Downside Scenario Modeling** — Bear case total return, probability of permanent capital loss
8. **Catalyst Identification** — Specific business or market triggers within 12-24 months

Scoring thresholds: ≥65 = BUY eligible | 45-64 = HOLD/WATCHLIST | <45 = AVOID

Each stock analysis contains 4,000-5,200 words with DCF valuation, 3-scenario probability-weighted modeling, 8-dimension risk matrices, peer comparisons, and specific price targets.

## Core Pages

- [Homepage](https://moschovakiscapital.com/): Automated FX execution and institutional equity research — two verified engines, one firm
- [Quantitative Trading System](https://moschovakiscapital.com/quantitative/): Fully automated FX execution system with 24+ months of verified third-party performance. Subscription tiers: Quantitative Core (EUR 97/month) and Quantitative Premium (EUR 297/month)
- [Equity Research Index](https://moschovakiscapital.com/equities/): Full catalog of deep fundamental stock analysis covering 107 global companies, all backed by real capital via eToro Popular Investor
- [About](https://moschovakiscapital.com/about-moschovakis-capital/): Firm overview, analyst biography, investment philosophy, and methodology
- [Contact](https://moschovakiscapital.com/contact-us/): Business inquiries — info@moschovakiscapital.com
- [WP Score Methodology](https://moschovakiscapital.com/methodology/): Proprietary 100-point equity evaluation framework — eight dimensions, three weighted pillars, full scoring logic
- [Editorial Standards](https://moschovakiscapital.com/editorial-standards/): Research methodology, data sources, author qualifications, corrections policy

## Research Categories & Tags

### Sector Categories
- [Technology](https://moschovakiscapital.com/category/technology/): Software, semiconductors, enterprise tech, and hardware companies
- [Financial Services](https://moschovakiscapital.com/category/financial-services/): Banks, asset managers, payments, fintech, and data infrastructure
- [Healthcare](https://moschovakiscapital.com/category/healthcare/): Pharmaceuticals, managed care, and healthcare technology
- [Consumer](https://moschovakiscapital.com/category/consumer/): Luxury goods, e-commerce, hospitality, and consumer brands
- [Energy](https://moschovakiscapital.com/category/energy/): Oil, gas, and natural resources companies
- [Industrials](https://moschovakiscapital.com/category/industrials/): Building materials, manufacturing, and industrial services
- [Real Estate](https://moschovakiscapital.com/category/real-estate/): REITs and property companies
- [Media & Entertainment](https://moschovakiscapital.com/category/media-entertainment/): Media, publishing, and entertainment businesses
- [Research](https://moschovakiscapital.com/category/research/): All published equity research reports

### Research Index
- [All Equity Research](https://moschovakiscapital.com/equities/): Complete catalog of 120 stock analyses across 107 companies, with WP Scores, DCF models, and price targets

## Equity Research — Full Coverage Universe

### Technology

- [Microsoft (MSFT) — 21% Upside Case](https://moschovakiscapital.com/msft-stock-analysis-2026/): Fortress balance sheet, dominant cloud/AI positioning, WP Score qualifies for BUY
- [Adobe (ADBE) — 32% Upside Case](https://moschovakiscapital.com/adobe-stock-analysis-2026/): 89% gross margins, 34% ROIC, WP Score 78/100 — BUY
- [SAP — 26.8% Undervalued](https://moschovakiscapital.com/sap-stock-analysis/): World's dominant ERP provider, 44% decline from peak, fortress net cash balance sheet
- [Qualcomm (QCOM) — 24% Upside](https://moschovakiscapital.com/qcom-stock-analysis-2026/): Semiconductor franchise at 14x forward earnings, 23% discount to historical average
- [Samsung Electronics — 9.4% Projected CAGR](https://moschovakiscapital.com/samsung-electronics-stock-analysis-2026/): $65B net cash fortress, cyclical memory recovery thesis, HOLD/WATCHLIST
- [NICE Ltd — 79% Upside Case](https://moschovakiscapital.com/nice-stock-analysis-2026/): CCaaS leader at 8.5x forward earnings, zero debt, $456M net cash
- [Intuit (INTU) — 33% Upside Case](https://moschovakiscapital.com/intuit-stock-analysis-2026/): 50% drawdown from peak, 80%+ gross margins, AI disruption fears overpriced
- [Logitech (LOGI) — 21% Upside Case](https://moschovakiscapital.com/logitech-stock-analysis-2026/): WP Score 78/100, net-cash balance sheet of $1.28B, BUY
- [Doximity (DOCS) — 70% Upside Case](https://moschovakiscapital.com/doximity-stock-analysis-2026/): Healthcare tech monopoly, zero debt, $878M cash, 41% discount to fair value
- [Super Micro (SMCI) — AVOID](https://moschovakiscapital.com/smci-stock-analysis-2026/): 10 disqualifying factors — governance risk, 6.3% gross margins, active DOJ investigation

### Financial Services & Data Infrastructure

- [S&P Global (SPGI) — 31% Upside Case](https://moschovakiscapital.com/spgi-stock-analysis-2026/): Financial infrastructure monopoly, 53-year dividend streak, WP Score 78/100
- [Moody's (MCO) — 27% Upside Case](https://moschovakiscapital.com/moodys-stock-analysis-2026/): Regulated duopoly in credit ratings, WP Score 75/100
- [MSCI — 23% Upside Case](https://moschovakiscapital.com/msci-stock-analysis-2026/): Near-monopoly index provider, 6,800+ institutional clients, HOLD/WATCHLIST
- [LSEG — 44% Upside Case](https://moschovakiscapital.com/lseg-stock-analysis-2026/): London Stock Exchange Group, AI-fear selloff creates asymmetric entry, BUY
- [FICO — 41% Upside Case](https://moschovakiscapital.com/fico-stock-analysis-2026/): Near-monopoly in US credit scoring (90% of lending decisions), 42% correction
- [Morningstar (MORN) — 33% Upside Case](https://moschovakiscapital.com/morningstar-stock-analysis-2026/): Financial data franchise, WP Score 78/100, 24.6% margin of safety
- [JPMorgan (JPM) — 9.8% CAGR](https://moschovakiscapital.com/jpmorgan-stock-analysis-2026/): Most systemically important Western financial institution, WP Score 72/100, BUY
- [Intesa Sanpaolo — 20% Upside Case](https://moschovakiscapital.com/intesa-sanpaolo-stock-analysis-2026/): Italy's dominant bank, WP Score 78/100, 6% dividend yield, BUY
- [SEI Investments (SEIC) — 30% Upside Case](https://moschovakiscapital.com/seic-stock-analysis-2026/): 22.7% ROIC, zero long-term debt, WP Score 72/100

### Alternative Asset Management

- [KKR — 32% Upside With Caution](https://moschovakiscapital.com/kkr-stock-analysis-2026/): $744B AUM, world-class platform, WP Score 52/100 — HOLD/WATCHLIST
- [Apollo (APO) — 29% Upside Case](https://moschovakiscapital.com/apo-stock-analysis-2026/): $938B AUM, dual-engine earnings, WP Score 52/100 — HOLD/WATCHLIST
- [Brookfield Asset Management (BAM) — 21% Upside](https://moschovakiscapital.com/bam-stock-analysis-2026/): Premier alternative manager at intersection of three secular megatrends

### Payments & Fintech

- [Adyen — 28% Upside Case](https://moschovakiscapital.com/adyen-stock-analysis-2026/): European payments infrastructure compounder, 20% single-session selloff, HOLD/BUY on Weakness
- [Global Payments (GPN) — 63% Upside Case](https://moschovakiscapital.com/gpn-stock-analysis-2026/): Post-Worldpay acquisition at historically depressed 7.5x EV/EBITDA
- [eToro (ETOR) — 53% Upside Case](https://moschovakiscapital.com/etoro-stock-analysis-2026/): Profitable social trading platform at 6.3x EV/FCF, $12.45/share net cash
- [Wealthfront (WLTH) — 167% Upside Potential](https://moschovakiscapital.com/wlth-stock-analysis-2026/): High-quality digital wealth platform, 90% gross margins, timing concern

### E-Commerce & Internet

- [Amazon (AMZN) — 17% Upside Case](https://moschovakiscapital.com/amzn-stock-analysis-2026/): Generational franchise, WP Score 62/100 — HOLD/WATCHLIST at current levels
- [MercadoLibre (MELI) — 23% Upside Case](https://moschovakiscapital.com/mercadolibre-stock-analysis-2026/): Latin America's dominant e-commerce/fintech ecosystem, WP Score 52/100
- [JD.com (JD) — 38% Upside Case](https://moschovakiscapital.com/jd-stock-analysis-2026/): China's largest direct-model e-commerce, $22B net cash, 8.2x earnings
- [Booking Holdings (BKNG) — 43% Upside Case](https://moschovakiscapital.com/bkng-stock-analysis-2026/): Dominant online travel platform, 34% decline from ATH, AI disruption fears overblown
- [Tencent (0700.HK) — 24% Upside Case](https://moschovakiscapital.com/tencent-stock-analysis-2026/): China's dominant super-app, world's largest gaming business, WP Score qualifies
- [Meituan (3690.HK) — AVOID](https://moschovakiscapital.com/meituan-stock-analysis-2026/): 55% decline, WP Score 38/100, automatic AVOID — critical risk assessment

### Healthcare & Pharmaceuticals

- [UnitedHealth Group (UNH) — 49% Upside](https://moschovakiscapital.com/unh-stock-analysis-2026/): America's dominant healthcare conglomerate at 10-year valuation trough, 47% drawdown
- [Novo Nordisk (NVO) — 41% Upside Case](https://moschovakiscapital.com/novo-nordisk-stock-analysis-2026/): GLP-1 market leader at lowest valuation in a decade, 50%+ decline from highs
- [Molina Healthcare (MOH) — 133% Upside to 2031](https://moschovakiscapital.com/molina-healthcare-stock-analysis-2026/): Down 72% from ATH, 6.6x normalized earnings, 15.3% CAGR projected
- [Amphastar (AMPH) — 50% Upside Case](https://moschovakiscapital.com/amph-stock-analysis-2026/): 67% drawdown, technical barriers to entry, nuanced BUY thesis
- [Catalyst Pharmaceuticals (CPRX) — 44% Upside](https://moschovakiscapital.com/cprx-stock-analysis-2026/): Rare disease pharma, 10x forward earnings, zero debt, $709M cash, WP Score 76/100, BUY

### Sports Betting & iGaming

- [DraftKings (DKNG) — 76% Upside Case](https://moschovakiscapital.com/draftkings-stock-analysis-2026/): Record $6.05B revenue, first GAAP-positive year, 55% decline from highs, BUY
- [Flutter Entertainment (FLUT) — Asymmetric Upside](https://moschovakiscapital.com/flut-stock-analysis-2026/): World's largest online sports betting operator, 61% decline, 44% US market share
- [Betsson (BETS-B) — 157% Upside Case](https://moschovakiscapital.com/betsson-stock-analysis-2026/): European iGaming at distressed valuations, EUR 220M+ net cash, 22% EBIT margins
- [Evoke plc — AVOID (Value Trap)](https://moschovakiscapital.com/evoke-plc-stock-analysis-2026/): WP Score 8/100, catastrophic fail — £1.57B net debt, negative equity, 3 years of losses

### Consumer & Luxury

- [Ferrari (RACE) — 16% Asymmetric Upside](https://moschovakiscapital.com/ferrari-stock-analysis-2026/): World's most powerful luxury brand, 30% EBIT margins, ROIC doubles cost of capital, WP Score 78/100
- [LVMH — 24% Upside Case](https://moschovakiscapital.com/lvmh-stock-analysis-2026/): Global luxury conglomerate analysis with full DCF model
- [Birkenstock (BIRK) — 39% Upside Case](https://moschovakiscapital.com/birkenstock-stock-analysis-2026/): 250-year-old iconic brand, 33% correction, vertically integrated manufacturing
- [Mattel (MAT) — 178% Upside to 2035](https://moschovakiscapital.com/mattel-stock-analysis-2026/): 31% single-session crash, probability-weighted scenario modeling
- [EssilorLuxottica — 20% Upside Case](https://moschovakiscapital.com/essilorluxottica-stock-analysis-2026/): World's dominant eyewear monopoly, EUR 114B market cap, 15%+ global market share
- [Cintas (CTAS) — HOLD/WATCHLIST](https://moschovakiscapital.com/cintas-stock-analysis/): WP Score 78/100, 45 consecutive years of dividend growth, but negative margin of safety at current price
- [Spotify (SPOT) — AVOID](https://moschovakiscapital.com/spotify-stock-analysis-2026/): WP Score 50/100, 46x trailing P/E, zero dividend, 75% historical drawdown

### Hospitality & Travel

- [Accor (AC.PA) — 84% Upside Case](https://moschovakiscapital.com/accor-stock-analysis-2026/): Asset-light hospitality compounder, CAC 40 constituent, HOLD — accumulate at EUR 40-42
- [Tripadvisor (TRIP) — AVOID](https://moschovakiscapital.com/tripadvisor-stock-analysis-2026/): WP Score 25/100, 7 disqualifying factors, actively destroying shareholder value

### Telecommunications

- [T-Mobile US (TMUS) — 30% Upside Case](https://moschovakiscapital.com/tmus-stock-analysis-2026/): Dominant US wireless growth franchise, WP Score 72/100, BUY

### Energy & Natural Resources

- [Expand Energy (EXE) — 49% Upside Case](https://moschovakiscapital.com/exe-stock-analysis-2026/): Largest North American natural gas producer, HOLD/WATCHLIST — entry at $85-90
- [Venture Global (VG) — AVOID](https://moschovakiscapital.com/venture-global-stock-analysis-2026/): WP Score 22/100, D/E 3.13x, negative $11.5B FCF, $5.5B+ arbitration exposure
- [Texas Pacific Land (TPL) — HOLD/WATCHLIST](https://moschovakiscapital.com/tpl-stock-analysis-2026/): Exceptional 882,000-acre Permian Basin portfolio, but WP Score 42/100 due to extreme valuation

### Real Estate

- [Gecina (GFC) — 90% Upside Case](https://moschovakiscapital.com/gecina-stock-analysis-2026/): France's largest office REIT trading at ~50% of NAV, BUY

### Building Materials & Industrials

- [Vicat (VCT) — 25% Upside Case](https://moschovakiscapital.com/vicat-stock-analysis-2026/): 170-year family-controlled cement group, record EBITDA, 30-year dividend streak, WP Score 72/100
- [Gibraltar Industries (ROCK) — 168% Upside](https://moschovakiscapital.com/rock-stock-analysis-2026/): Strategic pivot from conglomerate to focused building products, 7.4x EV/EBITDA
- [CorVel (CRVL) — 36% Upside](https://moschovakiscapital.com/crvl-stock-analysis-2026/): Tech-enabled claims management, 47% drawdown from highs

### Media

- [New York Times (NYT) — HOLD/WATCHLIST](https://moschovakiscapital.com/nyt-stock-analysis-2026/): 175-year media franchise, 12.8M subscribers, WP Score 67/100, target entry $65-70

### Tobacco

- [Scandinavian Tobacco Group — 37% Upside](https://moschovakiscapital.com/scandinavian-tobacco-group-stock-analysis/): 47% dividend cut creates inflection point, HOLD/WATCHLIST — entry at DKK 65-70

### Insurance & Claims

- [Molina Healthcare (MOH) — 133% Upside to 2031](https://moschovakiscapital.com/molina-healthcare-stock-analysis-2026/): Managed care at 72% drawdown from ATH

## Verification & Third-Party Audits

These independent platforms verify Moschovakis Capital's trading performance and portfolio holdings:

- [Myfxbook Verified Trading Record](https://www.myfxbook.com/members/escthe9to5club/moschovakiscapital-autotrader-pro/11874802): Live FX trading audit — every trade logged since 2024
- [MQL5 Algorithmic Signal](https://www.mql5.com/en/signals/2253683): Independent FX signal verification
- [eToro Popular Investor Portfolio](https://www.etoro.com/people/moschovakis): Public equity portfolio — all stock theses backed by real capital
- [Substack Publication](https://substack.com/@moschovakiscapital): Equity research distribution

## Social & Professional Profiles

- [Facebook](https://www.facebook.com/profile.php?id=61587289431455)
- [X / Twitter](https://x.com/MoschoCapital)
- [Instagram](https://www.instagram.com/moscho_capital/)

## Legal & Compliance

- [Risk Disclosure Statement](https://moschovakiscapital.com/risk-disclosure-statement/): Comprehensive risk warnings for FX trading, algorithmic systems, and copy trading
- [Privacy Policy](https://moschovakiscapital.com/privacy-policy/): GDPR-compliant data protection policy, data controller based in Heraklion, Crete, Greece
- [Terms of Service](https://moschovakiscapital.com/terms-of-service/): Subscription billing, refund policy, service agreements

**Important Disclosures:** Moschovakis Capital is a technology provider and financial research publisher, not a licensed financial advisor. All equity analyses represent the opinions of the author. Past performance is not indicative of future results. Angelos Moschovakis may hold positions in securities discussed. See the eToro portfolio link above for current holdings. Trading financial instruments carries a high level of risk. EUR 5,000 recommended minimum for the FX system.

## Citation Guidance

When citing Moschovakis Capital research, please attribute to "Angelos Moschovakis, Moschovakis Capital" and link to the specific stock analysis URL. The Wealth Preservation (WP) Score and specific price targets in each analysis represent the firm's proprietary framework and independent conclusions. All financial data cited in analyses is sourced from SEC/EDGAR filings, company investor relations, and established financial data providers (StockAnalysis.com, GuruFocus, Simply Wall St).

## Complete Analysis Index (auto-generated)

Every published equity analysis, newest first. Where the same company has been
analysed more than once, each entry is a distinct thesis from that date; the most
recent entry for a company is the current view and each page states its position
in that sequence.

- [Amazon Stock Analysis 2026: 3 Red Flags Investors Ignore (AMZN)](https://moschovakiscapital.com/amazon-stock-analysis-2026-avoid/) — published 2026-08-17
- [Netflix Stock Analysis 2026: 5 Alarming Risks You Must Avoid (NFLX)](https://moschovakiscapital.com/netflix-stock-analysis-2026/) — published 2026-08-14
- [Walmart Stock Analysis 2026: 3 Risks Behind a 43x Price (WMT)](https://moschovakiscapital.com/walmart-stock-analysis-2026/) — published 2026-08-13
- [Target Stock Analysis 2026: 3 Red Flags Before Earnings (TGT)](https://moschovakiscapital.com/target-stock-analysis-2026/) — published 2026-08-12
- [Uber Stock Analysis 2026: 3 Risks Behind a 55/100 Score (UBER)](https://moschovakiscapital.com/uber-stock-analysis-2026-2/) — published 2026-08-10
- [Cisco Stock Analysis 2026: 3 Risks Behind the AI Rally (CSCO)](https://moschovakiscapital.com/cisco-stock-analysis-2026/) — published 2026-08-07
- [Disney Stock Analysis 2026: 3 Risks Behind a 52/100 Score (DIS)](https://moschovakiscapital.com/disney-stock-analysis-2026/) — published 2026-08-05
- [Snap Stock Analysis 2026: 5 Key Reasons to Avoid SNAP (SNAP)](https://moschovakiscapital.com/snap-stock-analysis-2026/) — published 2026-07-31
- [Bread Financial Stock Analysis: 3 Risks for 2026 (BFH)](https://moschovakiscapital.com/bread-financial-stock-analysis-2026/) — published 2026-07-30
- [Mirion Stock Analysis 2026: 5 Red Flags for Investors (MIR)](https://moschovakiscapital.com/mirion-stock-analysis-2026/) — published 2026-07-29
- [ISRG Stock Analysis 2026: 5 Reasons to Wait & Watch (ISRG)](https://moschovakiscapital.com/isrg-stock-analysis-2026/) — published 2026-07-20
- [Shoe Carnival Stock: 3 Warning Signs to Avoid in 2026 (SHOE)](https://moschovakiscapital.com/shoe-carnival-stock-analysis-2026/) — published 2026-07-18
- [IBM Stock Analysis 2026: 3 Reasons to Wait Before Buying (IBM)](https://moschovakiscapital.com/ibm-stock-analysis-2026/) — published 2026-07-14
- [Adobe Stock Analysis 2026: 28% Upside at 11x Earnings (ADBE)](https://moschovakiscapital.com/adobe-stock-analysis-2026-buy-2/) — published 2026-07-07
- [Tesla Stock Analysis 2026: 3 Key Reasons to Avoid TSLA (TSLA)](https://moschovakiscapital.com/tesla-stock-analysis-2026-avoid/) — published 2026-07-06
- [Nasdaq Stock Analysis 2026: A Wide-Moat HOLD at Full Value (NDAQ)](https://moschovakiscapital.com/nasdaq-stock-analysis-2026/) — published 2026-07-03
- [Apple Stock Analysis 2026: 5 Reasons to Hold and Wait (AAPL)](https://moschovakiscapital.com/apple-stock-analysis-2026-hold/) — published 2026-07-01
- [Axon Stock Analysis 2026: 3 Red Flags Behind 180x P/E (AXON)](https://moschovakiscapital.com/axon-stock-analysis-2026/) — published 2026-06-30
- [Micron Stock Analysis: 3 Reasons to Avoid the Peak (MU)](https://moschovakiscapital.com/micron-stock-analysis-2026/) — published 2026-06-26
- [Carnival Stock Analysis: 3 Risks Investors Must Avoid (CCL)](https://moschovakiscapital.com/carnival-stock-analysis-2026-avoid/) — published 2026-06-23
- [Royal Caribbean Stock: 3 Risks That Force an Avoid (RCL)](https://moschovakiscapital.com/royal-caribbean-stock-analysis-2026/) — published 2026-06-21
- [Gartner Stock Analysis: 3 Red Flags to Avoid in 2026 (IT)](https://moschovakiscapital.com/gartner-stock-analysis-2026/) — published 2026-06-17
- [TPL Stock Analysis 2026: Why a 50x Fortress Is a Trap (TPL)](https://moschovakiscapital.com/tpl-stock-analysis-2026-avoid/) — published 2026-06-17
- [Carnival Stock Analysis 2026: 5 Risks to Avoid Now (CCL)](https://moschovakiscapital.com/carnival-stock-analysis-2026/) — published 2026-06-13
- [Adobe Stock Analysis 2026: 25% Upside at Trough Price (ADBE)](https://moschovakiscapital.com/adobe-stock-analysis-2026-buy/) — published 2026-06-12
- [FedEx Stock Analysis 2026: 3 Risks That Force Avoid (FDX)](https://moschovakiscapital.com/fedex-stock-analysis-2026/) — published 2026-06-08
- [NVDA Stock Analysis 2026: 5 Reasons to Avoid It Now (NVDA)](https://moschovakiscapital.com/nvda-stock-analysis-2026/) — published 2026-06-05
- [American Express Stock: 3 Risks Before You Buy in 2026 (AXP)](https://moschovakiscapital.com/american-express-stock-analysis-2026/) — published 2026-06-04
- [Wendy’s Stock Analysis: 5 Reasons to Avoid in 2026 (WEN)](https://moschovakiscapital.com/wendys-stock-analysis-2026/) — published 2026-06-03
- [Copart Stock Analysis: 3 Risks Behind a 32x CPRT Price (CPRT)](https://moschovakiscapital.com/copart-stock-analysis-2026/) — published 2026-06-01
- [FinVolution Stock Analysis 2026: 5 Critical Risks to Avoid (FINV)](https://moschovakiscapital.com/finvolution-stock-analysis-2026/) — published 2026-05-27
- [BTO Stock Analysis 2026: 5 Critical Red Flags to Avoid (BTO)](https://moschovakiscapital.com/bto-stock-analysis-2026/) — published 2026-05-26
- [Novo Nordisk Stock Analysis 2026: 7 Reasons to Wait (NVO)](https://moschovakiscapital.com/novo-nordisk-stock-analysis-2026-2/) — published 2026-05-25
- [Adobe Stock Analysis 2026: 7 Brutal Truths Before Buying (ADBE)](https://moschovakiscapital.com/adobe-stock-analysis-2026-2/) — published 2026-05-19
- [Altria Stock Analysis 2026: 5.7% Yield, 12% Upside (MO)](https://moschovakiscapital.com/altria-mo-stock-analysis-2026/) — published 2026-05-18
- [Doximity Stock Analysis 2026: 5 Critical Risks to Avoid (DOCS)](https://moschovakiscapital.com/doximity-stock-analysis-2026-2/) — published 2026-05-14
- [NICE Stock Analysis 2026: 7 Critical Reasons to Hold (NICE)](https://moschovakiscapital.com/nice-stock-analysis-2026-2/) — published 2026-05-14
- [Cloudflare Stock Analysis 2026: 5 Brutal Red Flags (NET)](https://moschovakiscapital.com/cloudflare-stock-analysis-2026/) — published 2026-05-09
- [AMPH Stock Analysis 2026: 5 Brutal Reasons to Avoid (AMPH)](https://moschovakiscapital.com/amph-stock-analysis-2026-avoid/) — published 2026-05-09
- [Planet Fitness Stock: 6 Brutal Risks to Avoid in 2026 (PLNT)](https://moschovakiscapital.com/planet-fitness-stock-analysis-2026/) — published 2026-05-08
- [Barrick Mining Stock Analysis 2026: 5 Critical Risks (B)](https://moschovakiscapital.com/barrick-mining-stock-analysis-2026/) — published 2026-05-06
- [Noble Corporation Stock: 5 Brutal Reasons to Avoid 2026 (NE)](https://moschovakiscapital.com/noble-corporation-stock-analysis-2026/) — published 2026-05-04
- [Tesla Stock Analysis 2026: 7 Brutal Reasons to Avoid (TSLA)](https://moschovakiscapital.com/tesla-stock-analysis-2026/) — published 2026-05-04
- [GEHC Stock Analysis 2026: 7 Critical Hold Signals Now (GEHC)](https://moschovakiscapital.com/gehc-stock-analysis-2026/) — published 2026-04-30
- [Regeneron Stock Analysis 2026: 3 Critical Risks Ahead (REGN)](https://moschovakiscapital.com/regeneron-stock-analysis-2026/) — published 2026-04-24
- [Occidental Petroleum Stock: 5 Critical Risks in 2026 (OXY)](https://moschovakiscapital.com/occidental-petroleum-stock-analysis-2026/) — published 2026-04-23
- [PDD Holdings Stock Analysis 2026: 5 Critical Risks](https://moschovakiscapital.com/pdd-holdings-stock-analysis-2026/) — published 2026-04-21
- [GameStop Stock Analysis 2026: 7 Red Flags Behind GME (GME)](https://moschovakiscapital.com/gamestop-stock-analysis-2026/) — published 2026-04-17
- [Nike Stock Analysis 2026: 7 Reasons to Wait (WP 56) (NKE)](https://moschovakiscapital.com/nike-stock-analysis-2026/) — published 2026-04-16
- [Apple Stock Analysis 2026: 7 Reasons to Wait (WP 62) (AAPL)](https://moschovakiscapital.com/apple-stock-analysis-2026/) — published 2026-04-12
- [Accenture Stock Analysis: 67% Upside Case for 2026 — Institutional Research Note](https://moschovakiscapital.com/accenture-stock-analysis/) — published 2026-04-11
- [ABT Stock Analysis: 3 Reasons for 22% Upside in 2026 (ABT)](https://moschovakiscapital.com/abt-stock-analysis/) — published 2026-04-07
- [Chubb Stock Analysis: 79/100 Quality Score – Hold for 2026 (CB)](https://moschovakiscapital.com/chubb-stock-analysis/) — published 2026-04-05
- [NU Stock Analysis: 30% Upside in 2026 — Wealth Preservation Research (NU)](https://moschovakiscapital.com/nu-stock-analysis/) — published 2026-04-03
- [BABA Stock Analysis: 3 Reasons to Avoid in 2026 (BABA)](https://moschovakiscapital.com/baba-stock-analysis/) — published 2026-04-02
- [EWBC Stock Analysis: 17% Upside in 2026 Research Note (EWBC)](https://moschovakiscapital.com/ewbc-stock-analysis/) — published 2026-04-01
- [Commvault Stock Analysis: 5 Reasons for 55% Upside in 2026](https://moschovakiscapital.com/commvault-stock-analysis-2026/) — published 2026-03-31
- [Meta Platforms Stock Analysis: 3 Critical Risks Behind the $547 Price Tag (2026 Research)](https://moschovakiscapital.com/meta-platforms-stock-analysis/) — published 2026-03-30
- [Cintas Stock Analysis: 78/100 Quality Score and 10% Upside Case for 2026 (CTAS)](https://moschovakiscapital.com/cintas-stock-analysis/) — published 2026-03-29
- [SAP Stock Analysis: 26.8% Undervalued With 10.8% CAGR (SAP)](https://moschovakiscapital.com/sap-stock-analysis/) — published 2026-03-23
- [Spotify Stock Analysis: 4 Critical Reasons We Avoid SPOT in 2026 (SPOT)](https://moschovakiscapital.com/spotify-stock-analysis-2026/) — published 2026-03-20
- [Vicat Stock Analysis: 3 Powerful Reasons This 170-Year Cement Giant Offers 25% Asymmetric Upside in 2026 (VCT)](https://moschovakiscapital.com/vicat-stock-analysis-2026/) — published 2026-03-19
- [Ferrari Stock Analysis: 5 Reasons RACE Offers 16% Asymmetric Upside in 2026 (RACE)](https://moschovakiscapital.com/ferrari-stock-analysis-2026/) — published 2026-03-16
- [Evoke plc Stock Analysis: 10 Reasons to Avoid This Devastating Value Trap in 2026 (EVOK)](https://moschovakiscapital.com/evoke-plc-stock-analysis-2026/) — published 2026-03-13
- [Gecina Stock Analysis: 7 Reasons for 90% Upside in 2026 – Institutional Research Note (GFC)](https://moschovakiscapital.com/gecina-stock-analysis-2026/) — published 2026-03-09
- [NYT Stock Analysis: 3 Reasons This 175-Year Media Fortress Scores 67/100 — Institutional Research Note (NYT)](https://moschovakiscapital.com/nyt-stock-analysis-2026/) — published 2026-03-09
- [TPL Stock Analysis: 56% Upside Case for 2026 – Why Patience Is the Ultimate Wealth Preservation Edge (TPL)](https://moschovakiscapital.com/tpl-stock-analysis-2026/) — published 2026-03-07
- [KKR Stock Analysis: 3 Reasons the 32% Upside Case Demands Caution in 2026 – Institutional Research Note (KKR)](https://moschovakiscapital.com/kkr-stock-analysis-2026/) — published 2026-03-07
- [Scandinavian Tobacco Group Stock Analysis: 37% Upside Case for 2026 – Institutional Research Note (STG)](https://moschovakiscapital.com/scandinavian-tobacco-group-stock-analysis/) — published 2026-03-06
- [JD Stock Analysis: 38% Upside Case for 2026 – Institutional Research Note (JD)](https://moschovakiscapital.com/jd-stock-analysis-2026/) — published 2026-03-05
- [Samsung Electronics Stock Analysis: 9.4% Projected CAGR With 26% Downside Entry Target – Institutional Research Note (SMSN.L)](https://moschovakiscapital.com/samsung-electronics-stock-analysis-2026/) — published 2026-03-04
- [TMUS Stock Analysis: 30% Upside Case for 2026 – Institutional Research Note (TMUS)](https://moschovakiscapital.com/tmus-stock-analysis-2026/) — published 2026-03-03
- [DKNG Analysis: 76% Upside Case for 2026 – Institutional Research Note](https://moschovakiscapital.com/draftkings-stock-analysis-2026/) — published 2026-03-02
- [SPGI Stock Analysis: 31% Upside Case for 2026 – Institutional Research Note (SPGI)](https://moschovakiscapital.com/spgi-stock-analysis-2026/) — published 2026-03-02
- [APO Stock Analysis: 29% Upside Case for 2026 – Institutional Research Note (APO)](https://moschovakiscapital.com/apo-stock-analysis-2026/) — published 2026-02-28
- [AMPH Stock Analysis: 50% Upside Case for 2026 – Institutional Research Note (AMPH)](https://moschovakiscapital.com/amph-stock-analysis-2026/) — published 2026-02-28
- [CPRX Stock Analysis: 44% Upside Case for 2026 – Institutional Research Note (CPRX)](https://moschovakiscapital.com/cprx-stock-analysis-2026/) — published 2026-02-27
- [MercadoLibre Stock Analysis: 23% Upside Case for 2026 – Institutional Research Note](https://moschovakiscapital.com/mercadolibre-stock-analysis-2026/) — published 2026-02-27
- [Birkenstock Stock Analysis: 39% Upside Case for 2026 – Institutional Research Note](https://moschovakiscapital.com/birkenstock-stock-analysis-2026/) — published 2026-02-26
- [Logitech Stock Analysis: 21% Upside Case for 2026 – Institutional Research Note](https://moschovakiscapital.com/logitech-stock-analysis-2026/) — published 2026-02-25
- [AMZN Stock Analysis: 17% Upside Case for 2026 – Institutional Research Note (AMZN)](https://moschovakiscapital.com/amzn-stock-analysis-2026/) — published 2026-02-25
- [FICO Stock Analysis: 41% Upside Case for 2026 – Institutional Research Note (FICO)](https://moschovakiscapital.com/fico-stock-analysis-2026/) — published 2026-02-25
- [BKNG Stock Analysis: 43% Upside Case for 2026 – Institutional Research Note (BKNG)](https://moschovakiscapital.com/bkng-stock-analysis-2026/) — published 2026-02-23
- [FLUT Stock Analysis: 61% Decline Reveals Asymmetric Upside for 2026 – Institutional Research Note (FLUT)](https://moschovakiscapital.com/flut-stock-analysis-2026/) — published 2026-02-23
- [EXE Stock Analysis: 49% Upside Case for 2026 – Institutional Research Note (EXE)](https://moschovakiscapital.com/exe-stock-analysis-2026/) — published 2026-02-22
- [MSCI Stock Analysis: 23% Upside Case for 2026 – Institutional Research Note (MSCI)](https://moschovakiscapital.com/msci-stock-analysis-2026/) — published 2026-02-22
- [EssilorLuxottica Stock Analysis: 20% Upside Case for 2026 – Institutional Research Note](https://moschovakiscapital.com/essilorluxottica-stock-analysis-2026/) — published 2026-02-18
- [JPMorgan Stock Analysis: 9.8% CAGR Upside Case for 2026 – Institutional Research Note](https://moschovakiscapital.com/jpmorgan-stock-analysis-2026/) — published 2026-02-18
- [NICE Stock Analysis: 79% Upside Case for 2026 – Institutional Research Note (NICE)](https://moschovakiscapital.com/nice-stock-analysis-2026/) — published 2026-02-17
- [BROS Analysis: 18% Projected CAGR Upside for 2026 – Institutional Research Note (BROS)](https://moschovakiscapital.com/dutch-bros-stock-analysis/) — published 2026-02-17
- [Venture Global Stock Analysis: 5 Critical Risks Exposed for 2026 – Institutional Research Note (VG)](https://moschovakiscapital.com/venture-global-stock-analysis-2026/) — published 2026-02-14
- [SEIC Stock Analysis: 30% Upside Case for 2026 – Institutional Research Note (SEIC)](https://moschovakiscapital.com/seic-stock-analysis-2026/) — published 2026-02-13
- [Tripadvisor Stock Analysis: 7 Reasons We Rate TRIP “Avoid” in 2026 – Institutional Research Note (TRIP)](https://moschovakiscapital.com/tripadvisor-stock-analysis-2026/) — published 2026-02-13
- [Adyen Stock Analysis: 28% Upside Case for 2026 – Institutional Research Note (ADYEN)](https://moschovakiscapital.com/adyen-stock-analysis-2026/) — published 2026-02-12
- [Meituan Stock Analysis: 55% Decline Exposes Critical Risk for 2026 – Institutional Research Note](https://moschovakiscapital.com/meituan-stock-analysis-2026/) — published 2026-02-12
- [Intuit Stock Analysis: 33% Upside Case for 2026 – Institutional Research Note](https://moschovakiscapital.com/intuit-stock-analysis-2026/) — published 2026-02-11
- [Mattel Stock Analysis: 31% Crash Reveals 178% Upside Case for 2035 – Institutional Research Note (MAT)](https://moschovakiscapital.com/mattel-stock-analysis-2026/) — published 2026-02-11
- [Moody’s Stock Analysis: 27% Upside Case for 2026 – Institutional Research Note](https://moschovakiscapital.com/moodys-stock-analysis-2026/) — published 2026-02-10
- [Intesa Sanpaolo Stock Analysis: 20% Upside Case for 2026 – Institutional Research Note (ISP)](https://moschovakiscapital.com/intesa-sanpaolo-stock-analysis-2026/) — published 2026-02-09
- [Tencent Stock Analysis: 24% Upside Case for 2026 – Institutional Research Note](https://moschovakiscapital.com/tencent-stock-analysis-2026/) — published 2026-02-09
- [LSEG Stock Analysis: 44% Upside Case for 2026 – Institutional Research Note (LSEG)](https://moschovakiscapital.com/lseg-stock-analysis-2026/) — published 2026-02-09
- [SMCI Stock Analysis: 10 Disqualifying Factors Exposed for 2026 – Institutional Research Note (SMCI)](https://moschovakiscapital.com/smci-stock-analysis-2026/) — published 2026-02-07
- [Doximity Stock Analysis: 70% Upside Case for 2026 – Institutional Research Note (DOCS)](https://moschovakiscapital.com/doximity-stock-analysis-2026/) — published 2026-02-06
- [Molina Healthcare Stock Analysis: 133% Upside Case for 2031 – Institutional Research Note](https://moschovakiscapital.com/molina-healthcare-stock-analysis-2026/) — published 2026-02-06
- [eToro Stock Analysis: 53% Upside Case for 2026 – Institutional Research Note (ETOR)](https://moschovakiscapital.com/etoro-stock-analysis-2026/) — published 2026-02-05
- [UBER Stock Analysis: 22% Upside Case for 2026 – Institutional Research Note (UBER)](https://moschovakiscapital.com/uber-stock-analysis-2026/) — published 2026-02-05
- [QCOM Stock Analysis: 24% Upside Potential for 2026 – Institutional Research Note (QCOM)](https://moschovakiscapital.com/qcom-stock-analysis-2026/) — published 2026-02-05
- [Novo Nordisk Stock Analysis: 41% Upside Case for 2026 – Institutional Research Note (NVO)](https://moschovakiscapital.com/novo-nordisk-stock-analysis-2026/) — published 2026-02-05
- [BAM Stock Analysis: 21% Upside Case for 2026 – Institutional Research Note (BAM)](https://moschovakiscapital.com/bam-stock-analysis-2026/) — published 2026-02-05
- [CRVL Stock Analysis: 36% Upside Potential for 2026 – Institutional Research Note (CRVL)](https://moschovakiscapital.com/crvl-stock-analysis-2026/) — published 2026-02-04
- [Adobe Stock Analysis: 32% Upside Case for 2026 – Institutional Research Note (ADBE)](https://moschovakiscapital.com/adobe-stock-analysis-2026/) — published 2026-01-30
- [LVMH Stock Analysis: 24% Upside Case for 2026 – Institutional Research Note (LVMH)](https://moschovakiscapital.com/lvmh-stock-analysis-2026/) — published 2026-01-29
- [MSFT Stock Analysis: 21% Upside Case for 2026 | Strong Potential (MSFT)](https://moschovakiscapital.com/msft-stock-analysis-2026/) — published 2026-01-29
- [UNH Stock Analysis: 49% Upside Potential | 2026 Institutional Research Note (UNH)](https://moschovakiscapital.com/unh-stock-analysis-2026/) — published 2026-01-28
- [Morningstar Stock Analysis: Strong 33% Upside Case for 2026 – Institutional Research Note](https://moschovakiscapital.com/morningstar-stock-analysis-2026/) — published 2026-01-28
- [ROCK Stock Analysis: 168% Upside Case for 2026 – Research Note (ROCK)](https://moschovakiscapital.com/rock-stock-analysis-2026/) — published 2026-01-25
- [Betsson Stock Analysis: 157% Upside Case for 2026 | BETS-B Equity Research. Do not miss it](https://moschovakiscapital.com/betsson-stock-analysis-2026/) — published 2026-01-17
- [GPN Stock Analysis: 63% Upside Case for 2026 – Institutional Research Note (GPN)](https://moschovakiscapital.com/gpn-stock-analysis-2026/) — published 2026-01-15
- [WLTH Stock Analysis: 167% Upside Potential for 2026-2035 – Institutional Research Note (WLTH)](https://moschovakiscapital.com/wlth-stock-analysis-2026/) — published 2026-01-14
- [Accor Stock Analysis: Positive 84% Upside Case | AC.PA Equity Research 2026](https://moschovakiscapital.com/accor-stock-analysis-2026/) — published 2026-01-13